Related Experiment Video
Updated: Jun 15, 2026
05:31
Gas Chromatography-Mass Spectrometry Paired with Total Vaporization Solid-Phase Microextraction as a Forensic Tool
Published on: May 25, 2021
Gamma-hydroxybutyrate withdrawal syndrome: a case report
Michael A Kuiper1, Nicole Peikert, E Christiaan Boerma
1Department of Intensive Care Medicine, Medical Centre Leeuwarden, P.O. Box 888, 8901 BR Leeuwarden, The Netherlands; Department of Intensive Care Medicine, Academic Medical Centre Amsterdam Hermes Critical Care Group, The Netherlands. mi.kuiper@wxs.nl
Cases Journal
|February 26, 2010
Summary
Healthcare workers must recognize the risks of gamma-hydroxybutyric acid (GHB) withdrawal. This potentially life-threatening condition requires prompt diagnosis and multidisciplinary management for better patient outcomes.
Area of Science:
- Addiction Medicine
- Neuroscience
- Critical Care
Background:
- Gamma-hydroxybutyric acid (GHB) abuse can lead to severe withdrawal symptoms.
- Healthcare providers may not recognize the signs of GHB withdrawal.
- Intense GHB abuse poses significant health risks.
Purpose of the Study:
- To increase awareness of GHB withdrawal risks among healthcare workers.
- To highlight the critical need for recognizing and managing GHB withdrawal.
- To emphasize the potential severity of GHB addiction and its consequences.
Main Methods:
- Case presentation of a 23-year-old female with GHB addiction.
- Detailed description of unrecognized GHB withdrawal symptoms.
- Intensive Care Unit (ICU) admission for airway support and mechanical ventilation.
- Treatment with high-dose benzodiazepines.
Main Results:
- Initial GHB withdrawal symptoms were unrecognized, leading to patient deterioration.
- ICU admission was necessary for respiratory support.
- Benzodiazepine treatment facilitated recovery and ventilator liberation.
Conclusions:
- GHB withdrawal is often underdiagnosed by physicians in Emergency Departments, ICUs, and psychiatric wards.
- Effective management requires a better understanding of GHB withdrawal symptoms and treatment protocols.
- Early identification of GHB withdrawal is crucial for preventing life-threatening complications and improving patient care.
Related Concept Videos
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...